Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
fda
6
×
life sciences
national blog main
6
×
san francisco top stories
6
×
national top stories
new york top stories
san francisco blog main
boston blog main
boston top stories
new york blog main
san diego blog main
san diego top stories
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drugs
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
genentech
merck
pfizer
roche
san francisco
4d molecular therapeutics
abbvie
acne
agenus
What
approved
6
×
drug
fda
medicine
friday
new
oral
pharmaceuticals
therapy
time
afternoon
agency
ago
aimmune
allergy
alnylam
alnylam’s
approval
atrophy
awarded
battle
bio
cancer
cannabis
companies
daily
data
deeper
derivative
developed
digital
disease
dna
epidemic
epilepsy
evrysdi
fatty
fingerprint
form
frenzied
Language
unset
Current search:
approved
×
fda
×
" national blog main "
×
" san francisco top stories "
×
@xconomy.com
4 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
6 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
6 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug